Menu
Share
Share this story
Close X
 
Switch to Desktop Site

DRUG BUREAU CHIEF DEFENDS FDA ON PAYOFFS

The head of the US Food and Drug Administration (FDA) said July 11 that generic drug companies are partly to blame for a payoff scandal in his agency. After 1984 reforms made it easier to put generic drugs on the market, ``many generic drug companies did not hesitate to exert tremendous pressure on FDA drug reviewers,'' FDA Commissioner Frank Young told a House subcommittee.

A year-long federal grand jury probe has so far led to charges of criminal wrongdoing against three FDA employees and three generic drug company executives.

About these ads